These effects are mediated by regulating the expression of proangiogenic factors such as Cox-2, VEGF, Ang-1, and eNOS.29, 30, 31, 32, 33, 34 Consistently, our results showed that serum levels of VEGF and Ang-1 were both lower in patients with sarcopenia. Here, VEGFA is linked to sarcopenia.